June 11, 2025 - 00:00

A recent study has projected significant growth in the roll-to-roll (R2R) technologies market for flexible devices, estimating it will reach $69.8 billion by 2029. This growth represents a remarkable compound annual growth rate (CAGR) of 11.5% from 2024 to 2029.
The report delves into various factors driving this expansion, including advancements in manufacturing processes and increasing demand for lightweight, flexible electronic devices across multiple sectors. The rise of wearable technology, flexible displays, and solar cells are among the key applications fueling this growth.
Emerging technologies in the R2R sector are also highlighted, showcasing innovations that enhance production efficiency and reduce costs. As the market evolves, competition is intensifying, with numerous players striving to capture a share of this lucrative segment.
Overall, the findings underscore a promising future for roll-to-roll technologies, emphasizing the importance of continued investment in research and development to maintain competitive advantages in this rapidly growing market.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...